• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Clinical Intelligence Platform

Memora Health & Virtua Health Partner to Streamline Patient Experience

by Fred Pennic 02/07/2023 Leave a Comment

Memora Health & Virtua Health Partner to Streamline Patient Experience

What You Should Know: - Memora Health, an intelligent platform for virtual care delivery and complex care management partners with Virtua Health, the largest health system in South Jersey, to streamline care delivery and improve the patient experience. - The partnership will leverage Memora’s clinical intelligence platform across specialties to automate clinicians’ routine care tasks and streamline care management operations with the goal of removing unnecessary barriers and making it
Read More

Nuance & Covera Launches Nationwide Radiology Quality Care

by Syed Hamza Sohail 08/17/2022 Leave a Comment

Nuance & Covera Launches Nationwide Radiology Quality Care

What You Should Know: - Covera Health, Inc. and Nuance Communications, Inc., today introduced the Quality Care Collaborative (QCC), the first national program that brings together payers, providers, and self-insured employers to support radiology quality improvement initiatives at scale. - The QCC joins Covera’s clinical intelligence platform and Nuance’s Precision Imaging Network™ to enable providers, payers, and employers to work together in a
Read More

H1 & Lokavant Partner to Power Next-Gen Clinical Trials

by Syed Hamza Sohail 08/03/2022 Leave a Comment

H1 & Lokavant Partner to Power Next-Gen Clinical Trials

What You Should Know: - H1and Lokavant today announced an extensive data-and-analytics collaboration to bring enhanced automated intelligence to drug development - As part of the bi-directional partnership, Lokavant will provide performance data on global trial sites and principal investigators from thousands of studies to supplement H1’s existing Trial Landscape clinical trial repository.  Integrating Clinical Trial Data Sources to Intelligence Platforms Lokavant is a clinical
Read More

UPMC Spins Out Realyze Intelligence for AI-Based Clinical Intelligence Platform

by Fred Pennic 06/03/2021 Leave a Comment

UPMC Spins Out Realyze Intelligence for AI-Based Clinical Intelligence Platform

What You Should Know: -  UPMC has launched Realyze Intelligence, a company that uses artificial intelligence and natural language processing to identify precise patient populations with chronic diseases and cancer to ensure they receive the most beneficial treatments. - Founded by Gilan El Saadawi, M.D., Ph.D and Aaron Brauser founded in conjunction with UPMC Enterprises, the innovation and commercialization arm of UPMC.  - The U.S. healthcare industry spends
Read More

KPMG, Waystar Integrates Social Determinants of Health Data to Clinical Intelligence Platform

by Fred Pennic 05/16/2019 Leave a Comment

IPA, IHANY, Fidelis Care Partner to Address Social Determinants of Health in Upstate New York AzHHA Taps PatientPing to Improve Care Coordination Across State of Arizona

KPMG announced it is integrating social determinants of health (SDoH) data from revenue cycle provider Waystar to KPMG’s Clinical Intelligence (KCI) platform. The integration will harness SDoH data that can help overcome obstacles to medical treatment and affect outcomes to help with care coordination.The Impact of Social Determinants of Health DataSocial, environmental and economic factors – such as transportation, housing, nutrition, and education level – can have a big impact upon medical
Read More

Decisio Health Lands $4.5M for FDA-Cleared Clinical Intelligence Platform

by Jasmine Pennic 05/18/2016 Leave a Comment

Decisio Health

Decisio Health, a Houston-based healthcare software company that helps acute-care provider organizations continually improve their clinical processes, announced today that it has raised $4.5 million in Series B funding. The round was led by DECLATEX, LLC with participation by the University of Texas Horizon Fund. The company also added Larry Lawson, founder of eCardio, as an investor and board member.In addition to the funding round, the company has launched their clinical intelligence
Read More

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Paradigm Shift in Diabetes Care with Studio Clinics: Q&A with Reach7 Founder Chun Yong

Most-Read

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

2019 MedTech Breakthrough Award Category Winners Announced

MedTech Breakthrough Announces 2025 MedTech Breakthrough Award Winners

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |